In addition to being effective in treating colitis, evidence in mice points towards TNF blockade enhancing the anti-tumour effects of ICI by increasing infiltration of tumour-specific T cells in the tumour and decreasing activation-induced cell death in CD8 + T cells [33]. This evidence concerns the gene CD8A and colitis.